# Vaxcyte, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/vaxcyte-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 34 |
| Claims under review | 2 |
| Evidence records | 13 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-17T04:45:33.016234+00:00 |
| Last reviewed | 2026-10-17T04:45:33.016234+00:00 |

## Identity

- Legal name: Vaxcyte, Inc.
- Display name: Vaxcyte, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-17T16:18:09.925373+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.806 |
| Directors | 8 |
| Committees | 6 |
| Governance events | 17 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Annie Drapeau: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (chair); Compensation · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:7
- Carlos Paya, M.D., Ph.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:8
- Grant E. Pickering: Director. Status: current. Independent: false. Since: 2013-01-01. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:9
- Halley Gilbert: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:10
- Jacks Lee: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member). claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:11
- John Furey: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:12
- Olivier Brandicourt: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:13
- Teri Loxam: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:14

## Committees

- Audit (audit). Chair: Teri Loxam. Members: Teri Loxam (chair, current); Halley Gilbert (member, current); Jacks Lee (member, current). committee_id=alpha:committee:vaxcyte-inc:audit
- Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Teri Loxam (member, current). committee_id=alpha:committee:vaxcyte-inc:audit-chair
- Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Halley Gilbert (member, current). committee_id=alpha:committee:vaxcyte-inc:audit-nominating-and-governance-chair
- Compensation (compensation). Chair: Annie Drapeau. Members: Annie Drapeau (chair, current); John Furey (member, current). committee_id=alpha:committee:vaxcyte-inc:compensation
- Compensation · Chair; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Annie Drapeau (member, current). committee_id=alpha:committee:vaxcyte-inc:compensation-chair-nominating-and-governance
- Nominating and Governance (nominating_governance). Chair: Halley Gilbert. Members: Halley Gilbert (chair, current); Annie Drapeau (member, current); Olivier Brandicourt (member, current). committee_id=alpha:committee:vaxcyte-inc:nominating-and-governance

## Executive leadership

- Harp Dhaliwal: Chief Technical Operations Officer. Status: current. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:18
- Jim Wassil: Executive Vice President and Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:21
- Andrew L. Guggenhime: President & Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:15
- Elvia Cowan: Senior Vice President of Finance. Status: unknown. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:16
- Grant E. Pickering: Co-Founder, Chief Executive Officer & Director [CEO]. Status: unknown. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:17
- James Wassil: Executive Vice President & Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:19
- Janet Graesser: Senior Vice President of Corporate Affairs. Status: unknown. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:20
- Mikhail Eydelman: Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:22
- Sam Iki: Senior Vice President of Project Management. Status: unknown. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:23
- Whitney Jones: Chief People Officer [CHRO]. Status: unknown. claim_id=alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:24

## Governance events

- EXECUTIVE_APPOINTED: Harp Dhaliwal executive of Vaxcyte, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:4w92hgamjcgm
- EXECUTIVE_APPOINTED: Jim Wassil executive of Vaxcyte, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:1y5jbao1ex95m0
- DIRECTOR_APPOINTED: Olivier Brandicourt seat on Vaxcyte, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:1tal4m2kj1uig
- DIRECTOR_APPOINTED: John Furey seat on Vaxcyte, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:1v36baor0xc8c
- COMMITTEE_MEMBER_ADDED: John Furey member of Compensation, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:1djfe1y14dvy1o
- DIRECTOR_APPOINTED: Jacks Lee seat on Vaxcyte, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:sew54o1047ozs
- DIRECTOR_APPOINTED: Annie Drapeau seat on Vaxcyte, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:jjjzr7bgdba1
- DIRECTOR_APPOINTED: Carlos Paya, M.D., Ph.D. seat on Vaxcyte, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:13vvioq14id60i
- DIRECTOR_APPOINTED: Teri Loxam seat on Vaxcyte, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:lim4jvtkze3z
- COMMITTEE_CREATED: Audit · Chair committee of Vaxcyte, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:m05ecjpr56lz
- COMMITTEE_MEMBER_ADDED: Teri Loxam member of Audit · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:6q4rrvtmjhfn
- COMMITTEE_CREATED: Compensation · Chair; Nominating and Governance committee of Vaxcyte, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:61s0hrewvri9
- COMMITTEE_MEMBER_ADDED: Annie Drapeau member of Compensation · Chair; Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:yt41t4mqtuaq
- DIRECTOR_APPOINTED: Halley Gilbert seat on Vaxcyte, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:1p3h2oe113xuru
- COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Vaxcyte, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:jn1b1m1rws7xm
- COMMITTEE_MEMBER_ADDED: Halley Gilbert member of Audit; Nominating and Governance · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:1sa6ctiorun0c
- DIRECTOR_APPOINTED: Grant E. Pickering seat on Vaxcyte, Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-17T04:45:33.016234+00:00. event_id=alpha:event:transition:kqnc2wrmtkfq

## Scoped resources

- `alpha://company/vaxcyte-inc` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record
- `alpha://company/vaxcyte-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=identity
- `alpha://company/vaxcyte-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=corporate-structure
- `alpha://company/vaxcyte-inc/board` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=board
- `alpha://company/vaxcyte-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=committees
- `alpha://company/vaxcyte-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=leadership
- `alpha://company/vaxcyte-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=ownership
- `alpha://company/vaxcyte-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=financials
- `alpha://company/vaxcyte-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=capital-structure
- `alpha://company/vaxcyte-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=compensation
- `alpha://company/vaxcyte-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=governance
- `alpha://company/vaxcyte-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=shareholder-governance
- `alpha://company/vaxcyte-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=audit
- `alpha://company/vaxcyte-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=legal
- `alpha://company/vaxcyte-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=risk
- `alpha://company/vaxcyte-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=cyber
- `alpha://company/vaxcyte-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=ai-governance
- `alpha://company/vaxcyte-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=agents
- `alpha://company/vaxcyte-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=ecosystem
- `alpha://company/vaxcyte-inc/events` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=events
- `alpha://company/vaxcyte-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=relationships
- `alpha://company/vaxcyte-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=assessments
- `alpha://company/vaxcyte-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:teri-loxam","name":"Teri Loxam"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:halley-gilbert","name":"Halley Gilbert"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jacks-lee","name":"Jacks Lee"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:annie-drapeau","name":"Annie Drapeau"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:john-furey","name":"John Furey"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:halley-gilbert","name":"Halley Gilbert"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:annie-drapeau","name":"Annie Drapeau"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:35: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:olivier-brandicourt","name":"Olivier Brandicourt"},"source_id":"board_seats"}`

## Leadership

- Annie Drapeau: Director, Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469.
- Carlos Paya, M.D., Ph.D.: Director. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469.
- Grant E. Pickering: Director. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:9. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469.
- Halley Gilbert: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469.
- Jacks Lee: Director, Audit. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:11. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469.
- John Furey: Director, Compensation. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:12. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469.
- Olivier Brandicourt: Director, Nominating and Governance. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:13. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469.
- Teri Loxam: Director, Audit · Chair. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:14. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469.
- Andrew L. Guggenhime: President & Chief Financial Officer. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f453f3a917a601879823cf6e01136b43f75accdb34c9992e1ca85ad123bb60cc.
- Elvia Cowan: Senior Vice President of Finance. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5860762316585dff1cc03a1a589b48bf3e44e2f3be86a08b1dec5b4a21f3c401.
- Grant E. Pickering: Co-Founder, Chief Executive Officer & Director. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8925d8322b5a640b7f04b001188effe1b503868e890a84d427912f0b58295c67.
- Harp Dhaliwal: Chief Technical Operations Officer. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:18. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1464f89061053a45763a46d1f6ed741f4704d833be9c658fc7c08b99db5a5b56.
- James Wassil: Executive Vice President & Chief Operating Officer. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c4782cc965cc061d67612b011647fe6afed5c5605efa1af38c88aa3acfbb8c4.
- Janet Graesser: Senior Vice President of Corporate Affairs. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2fab59d55d25bd44e8797214a449ad4981b086a4b68dad279d3a28002b495c41.
- Jim Wassil: Executive Vice President and Chief Operating Officer. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:21. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ca1aa6cadd13b94924dff4a32ddc105bea93609fa6794b1192f72a5fc3049744.
- Mikhail Eydelman: Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03bc924fd42229fb5092619bdf9c40a4997499528d5f1a2ecfc52a6d49a371ba.
- Sam Iki: Senior Vice President of Project Management. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7d7d0bc8b4e643d707c5e76a0617ec700493fd77793761ea8b5c617cace187b7.
- Whitney Jones: Chief People Officer. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:18409a2d59265e6b42a5395e6bd1315f50d4bb40b61471feabb303790aa67a68.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair Teri Loxam; Members Teri Loxam (Chair); Halley Gilbert; Jacks Lee. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.
- Compensation: Chair Annie Drapeau; Members Annie Drapeau (Chair); John Furey. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_record:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.
- Nominating and Governance: Chair Halley Gilbert; Members Halley Gilbert (Chair); Annie Drapeau; Olivier Brandicourt. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_record:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Vaxcyte, Inc.. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64f48b5c3bb9e9890f53e0671b19320468ff34e169a753603d30eed2d13393a1.

## Entity Status

- Public listing published. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64f48b5c3bb9e9890f53e0671b19320468ff34e169a753603d30eed2d13393a1.

## Published Fact

- US. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64f48b5c3bb9e9890f53e0671b19320468ff34e169a753603d30eed2d13393a1.
- Healthcare. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64f48b5c3bb9e9890f53e0671b19320468ff34e169a753603d30eed2d13393a1.

## Committee Appointment

- Teri Loxam: chair, Audit. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.
- Halley Gilbert: member, Audit. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.
- Jacks Lee: member, Audit. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.
- Annie Drapeau: chair, Compensation. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.
- John Furey: member, Compensation. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.
- Halley Gilbert: chair, Nominating and Governance. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.
- Annie Drapeau: member, Nominating and Governance. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.
- Olivier Brandicourt: member, Nominating and Governance. Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc.

## Security Listing

- PCVX (NASDAQ). Claim: alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:security_listing:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64f48b5c3bb9e9890f53e0671b19320468ff34e169a753603d30eed2d13393a1.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:64f48b5c3bb9e9890f53e0671b19320468ff34e169a753603d30eed2d13393a1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/vaxcyte-inc).
- alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469: [Vaxcyte Inc DEF 14A 2026-04-23](https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm).
- alpha:projection-evidence:document:f453f3a917a601879823cf6e01136b43f75accdb34c9992e1ca85ad123bb60cc: [Vaxcyte Inc key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PCVX).
- alpha:projection-evidence:document:5860762316585dff1cc03a1a589b48bf3e44e2f3be86a08b1dec5b4a21f3c401: [Vaxcyte Inc key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PCVX).
- alpha:projection-evidence:document:8925d8322b5a640b7f04b001188effe1b503868e890a84d427912f0b58295c67: [Vaxcyte Inc key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PCVX).
- alpha:projection-evidence:document:1464f89061053a45763a46d1f6ed741f4704d833be9c658fc7c08b99db5a5b56: [PCVX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm).
- alpha:projection-evidence:document:2c4782cc965cc061d67612b011647fe6afed5c5605efa1af38c88aa3acfbb8c4: [Vaxcyte Inc key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PCVX).
- alpha:projection-evidence:document:2fab59d55d25bd44e8797214a449ad4981b086a4b68dad279d3a28002b495c41: [Vaxcyte Inc key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PCVX).
- alpha:projection-evidence:document:ca1aa6cadd13b94924dff4a32ddc105bea93609fa6794b1192f72a5fc3049744: [PCVX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm).
- alpha:projection-evidence:document:03bc924fd42229fb5092619bdf9c40a4997499528d5f1a2ecfc52a6d49a371ba: PCVX executive roster source.
- alpha:projection-evidence:document:7d7d0bc8b4e643d707c5e76a0617ec700493fd77793761ea8b5c617cace187b7: [Vaxcyte Inc key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PCVX).
- alpha:projection-evidence:document:18409a2d59265e6b42a5395e6bd1315f50d4bb40b61471feabb303790aa67a68: [Vaxcyte Inc key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PCVX).
- alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc: [Audit](https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/vaxcyte-inc)
- [Public Markdown](https://registry.alpha.ac/companies/vaxcyte-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=jsonld)
- MCP resource: `alpha://companies/vaxcyte-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-17T16:18:09.708638+00:00; recorded 2026-10-17T16:18:09.708638+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.